Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism

Immunology and Cell Biology

Volumn 86, Issue 2, 2008, Pages 175-178

  Shahabi, Shahram ^a   Rasmi, Yousef ^a   Jazani, Nima Hosseini ^a   Hassan, Zuhair Muhammad ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Gastroesophageal reflux disease; Helicobacter pylori; Inflammation; Parasympathetic nervous system; Sympathetic nervous system

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; CHOLINERGIC SYSTEM; CYTOKINE RELEASE; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HELPER CELL; HUMAN; IMMUNE RESPONSE; LOWER ESOPHAGUS SPHINCTER; NEUROIMMUNOLOGY; PATHOGENESIS; REFLUX ESOPHAGITIS; STOMACH MUCOSA; STOMACH PROTECTION; SYMPATHETIC TONE; VAGUS NERVE STIMULATION;

ANTIGENS, BACTERIAL; CYTOKINES; ESOPHAGITIS, PEPTIC; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION MEDIATORS; SYMPATHETIC NERVOUS SYSTEM;

HELICOBACTER PYLORI;

EID: 39749164543     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100119     Document Type: Article

References (41)

1. Ahtaridis G, Snape Jr WJ, Cohen S. Lower esophageal sphincter pressure as an index of gastroesophageal acid reflux. Dig Dis Sci 1981; 26: 993-998.
2. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 2001; 49: 364-371.
3. Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. Jama 2002; 287: 1972-1981.
4. Penagini R, Carmagnola S, Cantu P. Review article: gastro-oesophageal reflux disease - pathophysiological issues of clinical relevance. Aliment Pharmacol Ther 2002; 16 (Suppl 4): 65-71.
5. Lanas AI, Blas JM, Ortego J, Soria J, Sainz R. Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci 1997; 42: 1003-1012.
6. Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 2001; 480-481: 189-200.
7. Orlando RC. Review article: oesophageal mucosal resistance. Aliment Pharmacol Ther 1998; 12: 191-197.
8. Unal S, Karakan T, Dogan I, Cindoruk M, Dumlu S. The influence of Helicobacter pylori infection on the prevalence of endoscopic erosive esophagitis. Helicobacter 2006; 11: 556-561.
9. Graham DY, Genta RM. Gastritis and helicobacter pylori. In: Goldman L, Ausiello D (eds). Cecil TextBook of Medicine, 22nd edn, Saunders: Philadelphia, 2004, pp 823.
10. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med 2006; 4: 14.
11. McColl KE. Review article: Helicobacter pylori and gastro-oesophageal reflux disease - the European perspective. Aliment Pharmacol Ther 2004; 20 (Suppl 8): 36-39.
12. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: 737.
13. Wu JC, Sung JJ, Ng EK, Go MY, Chan WB, Chan FK et al. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East. Am J Gastroenterol 1999; 94: 1790-1794.
14. Vigneri S, Termini R, Savarino V, Pace F. Review article: is Helicobacter pylori status relevant in the management of GORD? Aliment Pharmacol Ther 2000; 14 (Suppl 3): 31-42.
15. Budzynski J, Klopocka M, Bujak R, Swiatkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 2004; 16: 451-457.
16. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
17. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
18. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL et al. In vivo activation of antigen-specific CD4T cells. Annu Rev Immunol 2001; 19: 23-45.
19. Murray DR, Irwin M, Rearden CA, Ziegler M, Motulsky H, Maisel AS. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism. Circulation 1992; 86: 203-213.
20. Cao L, Hudson CA, Lawrence DA. Immune changes during acute cold/restraint stress-induced inhibition of host resistance to Listeria. Toxicol Sci 2003; 74: 325-334.
21. Yamaguchi T, Yoshida N, Tomatsuri N, Takayama R, Katada K, Takagi T et al. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int J Mol Med 2005; 16: 71-77.
22. Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 2007; 132: 154-165.
23. Campo SM, Capria A, Antonucci F, Martino G, Ciamei A, Rossini PM et al. Decreased sympathetic inhibition in gastroesophageal reflux disease. Clin Auton Res 2001; 11: 45-51.
24. Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19: 493-499.
25. Queiroz DM, Guerra JB, Rocha GA, Rocha AM, Santos A, De Oliveira AG et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004; 127: 73-79.
26. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006; 367: 2086-2100.
27. Matysiak-Budnik T, Laszewicz W, Lamarque D, Chaussade S. Helicobacter pylori and non-malignant diseases. Helicobacter 2006; 11 (Suppl 1): 27-31.
28. Pilotto A, Franceschi M, Leandro G, Rassu M, Bozzola L, Valerio G et al. Influence of Helicobacter pylori infection on severity of oesophagitis and response to therapy in the elderly. Dig Liver Dis 2002; 34: 328-331.
29. Mc Namara D, Buckley M, O'Morain C. Helicobacter pylori-induced duodenal ulcer frequently coincides with gastro-oesophageal reflux disease. Dig Liver Dis 2002; 34: 542-546.
30. Jovanovic IR, Milosavjevic TN, Jankovic GP, Micev MM, Dugalic PD, Saranovic D et al. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases? Med Sci Monit 2001; 7: 137-141.
31. Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007; 184: 227-231.
32. Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter 2004; 9: 278-283.
33. Tursi A. Onset of Crohn's disease after Helicobacter pylori eradication. Inflamm Bowel Dis 2006; 12: 1008-1009.
34. Vare PO, Heikius B, Silvennoinen JA, Karttunen R, Niemela SE, Lehtola JK et al. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001; 36: 1295-1300.
35. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci 2004; 223: 13-24.
36. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150: 823-832.
37. Shahabi S, Hassan ZM, Jazani NH. Any beneficial effects of mycobacteria on multiple sclerosis and experimental autoimmune encephalitis may include stimulation of the sympathetic nervous system. Med Hypotheses 2006; 67: 164-168.
38. Shahabi S, Hassan ZM, Jazani NH, Ebtekar M. Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 2006; 67: 900-903.
39. Christen U, von Herrath MG. Infections and autoimmunity - good or bad? J Immunol 2005; 174: 7481-7486.
40. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26: 260-267.
41. Sewell DL, Reinke EK, Hogan LH, Sandor M, Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 2002; 82: 101-110.